Haemoglobin A1c, acute hyperglycaemia and short-term prognosis in patients without diabetes following acute ST-segment elevation myocardial infarction

Diabetic Medicine

Volumn 29, Issue 12, 2012, Pages 1493-1500

  Liu, Y ^a   Yang, Y M ^a   Zhu, J ^a   Tan, H Q ^a   Liang, Y ^a   Li, J D ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ACUTE DISEASE; ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

ANTICOAGULANTS; BIOLOGICAL MARKERS; CHINA; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84869107576     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2012.03641.x     Document Type: Article

References (29)

1. Kosiborod M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 2005; 111: 3078-3086.
2. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000; 355: 773-778.
3. Leor J, Goldbourt U, Reicher-Reiss H, Kaplinsky E, Behar S; SPRINT Study Group. Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: incidence, risk factors, and outcome. Am J Med 1993; 94: 265-273.
4. Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism et al. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2008; 117: 1610-1619.
5. Malmberg K, Norhammar A, Wedel H, Ryden L. Glycometabolic state at admission: important risk marker of mortality in conventional treated patients with diabetes mellitus and acute myocardial infarction. Long-term results from the diabetes and insulin-glucose infusion in acute myocardial infarction (DIGAMI) study. Circulation 1999; 99: 2626-2632.
6. Wahab NN, Cowden EA, Pearce NJ, Gardner MJ, Merry H, ICONS Investigators et al. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era?J Am Coll Cardiol 2002; 40: 1748-1754.
7. Husband DJ, Alberti KG, Julian DG. 'Stress' hyperglycaemia during acute myocardial infarction: an indicator of pre-existing diabetes?Lancet 1983; ii: 179-181.
8. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA et al. Association of glycaemia with macrovascular and microvascular complications of Type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405-412.
9. Gerstein HC, Pogue J, Mann JF, Lonn E, Dagenais GR, McQueen M et al. The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis. Diabetologia 2005; 48: 1749-1755.
10. 1C assay in the diagnosis of diabetes. Diabetes Care 2009; 32: 1327-1334.
11. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 2000; 36: 959-969.
12. Killip T (III), Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol 1967; 20: 457-464.
13. Khaw KT, Wareham N, Luben R, Bingham S, Oakes S, Welch A et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European prospective investigation of cancer and nutrition (EPIC-Norfolk). BMJ 2001; 322: 15-18.
14. 1c to rate of major adverse cardiac events in nondiabetic patients undergoing percutaneous coronary revascularization. Am J Cardiol 2003; 92: 1282-1286.
15. Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010; 362: 800-811.
16. 1c is associated with a poor outcome after acute myocardial infarction. Am Heart J 2007; 154: 470-476.
17. Tenerz A, Nilsson G, Forberg R, Ohrvik J, Malmberg K, Berne C et al. Basal glucometabolic status has an impact on long-term prognosis following an acute myocardial infarction in non-diabetic patients. J Intern Med 2003; 254: 494-503.
18. Cao JJ, Hudson M, Jankowski M, Whitehouse F, Weaver WD. Relation of chronic and acute glycemic control on mortality in acute myocardial infarction with diabetes mellitus. Am J Cardiol 2005; 96: 183-186.
19. Hadjadj S, Coisne D, Mauco G, Ragot S, Duengler F, Sosner P et al. Prognostic value of admission plasma glucose and HbA in acute myocardial infarction. Diabet Med 2004; 21: 305-310.
20. Cakmak M, Cakmak N, Cetemen S, Tanriverdi H, Enc Y, Teskin O et al. The value of admission glycosylated hemoglobin level in patients with acute myocardial infarction. Can J Cardiol 2008; 24: 375-378.
21. Kosiborod M, Inzucchi SE, Krumholz HM, Xiao L, Jones PG, Fiske S et al. Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation 2008; 117: 1018-1027.
22. Goyal A, Mehta SR, Gerstein HC, Díaz R, Afzal R, Xavier D et al. Glucose levels compared with diabetes history in the risk assessment of patients with acute myocardial infarction. Am Heart J 2009; 157: 763-770.
23. Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendíc S, Rydén L et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002; 359: 2140-2144.
24. Bartnik M, Ryden L, Ferrari R, Malmberg K, Pyörälä K, Simoons M et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J 2004; 25: 1880-1890.
25. Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, Hata T et al. Is admission hyperglycaemia in non-diabetic patients with acute myocardial infarction a surrogate for previously undiagnosed abnormal glucose tolerance?Eur Heart J 2006; 27: 2413-2419.
26. Tenerz A, Nilsson G, Forberg R, Ohrvik J, Malmberg K, Berne C et al. Basal glucometabolic status has an impact on long-term prognosis following an acute myocardial infarction in non-diabetic patients. J Intern Med. 2003; 254: 494-503.
27. Timmer JR, Hoekstra M, Nijsten MW, van der Horst IC, Ottervanger JP, Slingerland RJ et al. Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary intervention. Circulation 2011; 124: 704-711.
28. Svensson AM, McGuire DK, Abrahamsson P, Dellborg M. Association between hyper- and hypoglycaemia and 2year all-cause mortality risk in diabetic patients with acute coronary events. Eur Heart J 2005; 26: 1255-1261.
29. Pinto DS, Skolnick AH, Kirtane AJ, Murphy SA, Barron HV, Giugliano RP et al. U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2005; 46: 178-180.